This article needs additional citations for verification .(September 2021) |
Council overview | |
---|---|
Formed | 1936 |
Preceding Council |
|
Jurisdiction | Australian Government |
Headquarters | Canberra |
Motto | Building a Healthy Australia |
Employees | 208 [1] : 2 |
Annual budget | A$1.13 billion (2020–21) [2] : 354 , [lower-alpha 1] |
Minister responsible | |
Council executive | |
Parent department | Department of Health and Aged Care |
Website | nhmrc |
The National Health and Medical Research Council (NHMRC) is the main statutory authority of the Australian Government responsible for medical research. It was the eighth largest research funding body in the world in 2016, [3] and NHMRC-funded research is globally recognised for its high quality. [4] Around 45% of all Australian medical research from 2008–12 was funded by the federal government, through the NHMRC. [5] : 14
As an independent arm of the Department of Health, the NHMRC funds high quality health and medical research, [6] builds research capability in Australia, support the translation of health and medical research into better health outcomes, and promote the ethics and integrity in research. Non-health research is funded by the Australian Research Council.
The National Health and Medical Research Council Act 1992 provides for NHMRC to pursue activities designed to:
NHMRC invests in health and medical research through its grant program. Funding received for health and medical research from the Australian Government and other sources through the Medical Research Endowment Account (MREA) amounted to $882.7 million in 2018–19. This amount was exclusive of NHMRC's administrative costs, which are funded separately to the MREA.
The funds invested by NHMRC are drawn from its Medical Research Endowment Account and from separate accounts established to hold philanthropic gifts and bequests.
One of NHMRC's primary responsibilities is supporting the effective and rapid translation of research findings into health policy and practice. Specific activities undertaken by NHMRC to support research translation include:
NHMRC is, formally, a council consisting of the Commonwealth, state and territory chief medical officers, as well as persons with expertise in a variety of areas including:
This Council advises the chief executive officer (CEO) and is supported by the Office of NHMRC.
Section 35 of the NHMRC Act 1992 allows the Minister for Health to establish Principal Committees to assist the council to carry out any of its functions.
Section 39 of the Act enables the CEO to establish working committees to help carry out the functions of the CEO, the council or a Principal Committee. Peer Review Panels are the most common type of working committee established by the CEO.
In May 1923, the Australian Government called a Premiers' Conference "to devise measures for the co-operation of the Commonwealth and the States and of States with States and to provide uniformity of legislation and administration on health matters". By agreement at the Conference, a Royal Commission on health was appointed in 1925.
The report of the commission (the Hone Report) recommended the constitution of a Federal Health Council as an advisory body which should meet at least annually for the purpose of reviewing co-operation between Commonwealth and State health authorities.
The Report also recommended that the Commonwealth should provide a fund in aid of research on health questions, and establish a Council to administer it.
In response to these recommendations, a Federal Health Council was established by the Governor-General (by Order-in-Council) in 1926. The secretariat to the council was provided by the Australian Government Department of Health, which was itself established in 1921.
The first meeting of the council was held on the 25 January 1927.
At its ninth session, in April 1936, the Council proposed a revision of its functions, and the Commonwealth responded to this recommendation, together with the previous proposals on research made by the Royal Commission on Health. In September 1936, a revised Order-in-Council created a National Health and Medical Research Council to replace the Federal Health Council.
In addition to its previous role advising the Commonwealth and states (but not territories, as these did not exist at that time) on public health questions, NHMRC was also able to provide advice on medical research, including advice to the Commonwealth on the expenditure of money on medical research. To support this latter activity, the Medical Research Endowment Act 1937 was passed. This Act established the Medical Research Endowment Fund to support medical research.
The National Health and Medical Research Council Act 1992 ( NHMRC Act 1992), which came into effect on 24 June 1993, provided a legislative basis for NHMRC.
In 1998, the Health and Medical Research Strategic Review committee, chaired by Mr Peter Wills AC, presented a report to the Australian Government (The Virtuous Cycle) which led to a significant increase in funding for the health and medical research sector through NHMRC.
Between 2000 and 2018, the number of NHMRC-funded grants – across all research grant schemes – increased from 1870 to 4241 active grants, and total expenditure from NHMRC's Medical Research Endowment Account increased from $170 million to $861 million: a fivefold increase in funding.
Following amendments to the NHMRC Act 1992, NHMRC became an independent statutory agency within the Health and Ageing portfolio on 1 July 2006.
The Strategic Review of Health and Medical Research in Australia (McKeon Review) was established by the Australian Government in late 2011, and the report of the Review was publicly released in April 2013. The Review recommended a 10-year strategic health and medical research plan for the nation and included recommendations relating to NHMRC.
As part of the 2014–15 Budget the Government announced the establishment of the $20 billion Medical Research Future Fund (MRFF). The MRFF provides funding to address medical research priorities, drive innovation, improve delivery of health care, boost the effectiveness of the health system, and contribute to economic growth. It therefore complements and enhances funding for health and medical research provided by NHMRC.
NHMRC is assisting the Department of Health and Aged Care to implement disbursements from the MRFF as a provisional grants hub, along with the Business Grants Hub within the Australian Department of Industry, Science and Resources. This assistance draws on NHMRC's application and assessment processes and the expertise available to NHMRC through the health and medical research sector and other sources.
Year | Event |
1921 | Australian Government Department of Health is established |
1923 | Australian Government calls a Premiers' Conference on health matters |
1925 | Report of the Royal Commission on Health (the Hone Report) released |
1926 | Governor-General in Council establishes the Federal Health Council |
1936 | Governor-General in Council establishes NHMRC |
1937 | Medical Research Endowment Act 1937 |
1982 | Review of NHMRC’s functions, structure and operations (Coghland-Shea Review) report released |
1984 | Independent committee appointed to examine the organisation, functions and membership of NHMRC |
1992 | National Health and Medical Research Council Act 1992 enacted |
1993 | External Review of the NHMRC (Bienenstock Review) report released |
1999 | Strategic Review of Health and Medical Research (Wills Review) report released, recommending significant increase to funding for health and medical research |
2000 | NHMRC Act 1992 amended, creating the position of NHMRC Chief Executive Officer (CEO) |
2005-06 | NHMRC Act 1992 amended, establishing NHMRC as an independent statutory agency |
2013 | Strategic Review of Health and Medical Research in Australia (McKeon Review) report released, recommending changes to NHMRC |
2018 | NHMRC's New Grant Program commences operation |
2019 | NHMRC's new research grants management system (Sapphire) commences operation |
The CEO is the accountable authority of NHMRC. The role of CEO was established in 2000 through a change to the NHMRC Act 1992.
The functions of the council, led by the chair, are to provide advice to the CEO in relation to the performance of his or her functions.
Tenure | Chair |
---|---|
1927-45 | Dr John Cumpston CMG |
1946-59 | Dr Arthur Metcalfe CBE |
1960-72 | Major General Sir William Refshauge, AC, CBE |
1973-82 | Dr Gwyn Howells CB |
1983-84 | Mr Lawrence Willett AO |
1984-87 | Mr Bernard McKay |
1987 | Mr AJ Ayers |
1988-90 | Professor John Chalmers AC |
1991-93 | Professor Diana Horvath AO |
1994-96 | Professor Richard Smallwood AO |
1997-99 | Professor Richard Larkins AC |
2000-03 | Professor Nick Saunders AO |
2003-05 | Professor John Shine AO |
2006-12 | Professor Michael Good AO |
2012-15 | The Hon Justice Annabelle Bennett AC |
2015-21 | Professor Bruce Robinson AC |
2021-24 | Professor Caroline Homer AO |
Prior to the establishment of the role of CEO, a number of the CEO's functions were performed by the Secretary of the council.
Tenure | Secretary |
---|---|
1926-1936 | Mr JL Fawcett |
1936-1946 | Mr JL Fawcett |
1947 | Mr J Barchard |
1948-1949 | Mr TE Moon |
1954-57 | Mr CC Clifford |
1958 | Mr SP Power |
1958-62 | Dr RE Richards |
1962-67 | Mr RHC Wells |
1968-72 | Dr RW Greville |
1972-79 | Dr KW Edmondson |
1980-83 | Dr D De Souza |
1983-87 | Dr RW Cumming |
1987-88 | Mr RE Wilson |
1988-94 | Mr J Loy |
1994-95 | Ms F Howarth |
1996 | Ms D Ariotti |
1997-00 | Mr R Wells |
2001-02 | Mrs J Campbell |
2002-06 | Mr L Bienkiewicz |
The Canada Council for the Arts, commonly called the Canada Council, is a Crown corporation established in 1957 as an arts council of the Government of Canada. It is Canada's public arts funder, with a mandate to foster and promote the study and enjoyment of, and the production of works in, the arts.
The National Institute of Mental Health (NIMH) is one of 27 institutes and centers that make up the National Institutes of Health (NIH). The NIH, in turn, is an agency of the United States Department of Health and Human Services and is the primary agency of the United States government responsible for biomedical and health-related research.
The Royal Commission on the Future of Health Care in Canada, also known as the Romanow Report, is a committee study led by Roy Romanow on the future of health care in Canada. It was delivered in November 2002.
The Australian Research Council (ARC) is the primary non-medical research funding agency of the Australian Government, distributing more than A$800 million in grants each year. The Council was established by the Australian Research Council Act 2001, and provides competitive research funding to academics and researchers at Australian universities. Most health and medical research in Australia is funded by the more specialised National Health and Medical Research Council (NHMRC), which operates under a separate budget.
Research Councils UK, sometimes known as RCUK, was a non-departmental public body that coordinated science policy in the United Kingdom from 2002 to 2018. It was an umbrella organisation that coordinated the seven separate research councils that were responsible for funding and coordinating academic research for the arts, humanities, science and engineering. In 2018 Research Councils transitioned into UK Research and Innovation (UKRI).
The Australian Federal Police Association (AFPA) is a registered Industrial Organisation under the Fair Work Act 2009 operating as a Branch of the Police Federation of Australia. The AFPA has sole autonomous political and industrial coverage for all employees within the Australian Federal Police which includes sworn Federal Agents; Police Officers; Protective Service Officers; and non-sworn support staff deployed nationally and overseas. The Australian Federal Police Association also provides industrial coverage for the Australian Crime Commission and the Australian Commission for Law Enforcement Integrity.
On December 19, 2006, the Pandemic and All-Hazards Preparedness Act (PAHPA), Public Law No. 109-417, was signed into law by President George W. Bush. First introduced in the House by Rep. Mike Rogers (R-MI) and Rep. Anna Eshoo (D-CA), PAHPA had broad implications for the United States Department of Health and Human Services's (HHS) preparedness and response activities. Among other things, the act amended the Public Health Service Act to establish within the department a new Assistant Secretary for Preparedness and Response (ASPR); provided new authorities for a number of programs, including the advanced development and acquisitions of medical countermeasures; and called for the establishment of a quadrennial National Health Security Strategy.
The National Transport Commission (NTC), previously known as the National Road Transport Commission, is an Australian statutory body created to develop regulatory and operational reform for road, rail and intermodal transport.
The Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) is a regulatory agency under the Commonwealth of Australia that aims to protect Australian citizens from both ionising and non-ionising radiation. ARPANSA works under the guidance of the Australian Radiation Protection and Nuclear Safety Act of 1998 as the national regulatory body of radiation in Australia, with independent departments within each state and territory that regulate radiation within each of their jurisdictions.
The Australian College of Optometry (ACO) is an Australian non-profit working to improve the eye health and well-being of various Australian communities. Established in 1940, the ACO's goal is to deliver public health optometry, vision research and professional education.
Brendan Scott CrabbFASM is an Australian microbiologist, research scientist and director and chief executive officer of the Burnet Institute, based in Melbourne, Victoria, Australia.
The Friends of Science In Medicine (FSM) is an Australian association which supports evidence-based medicine and strongly opposes the promotion and practice of unsubstantiated therapies that lack a scientifically plausible rationale. They accomplish this by publicly raising their concerns either through direct correspondence or through media outlets. FSM was established in December 2011 by Loretta Marron, John Dwyer, Alastair MacLennan, Rob Morrison and Marcello Costa, a group of Australian biomedical scientists and clinical academics.
The South Australian Health and Medical Research Institute (SAHMRI) is an independent health and medical research institute in Adelaide, South Australia. The institute is housed in a purpose-built eponymous building with its iconic "cheese-grater" design created by architects Woods Bagot, located in South Australia's health and biomedical precinct on North Terrace, just east of the Royal Adelaide Hospital.
The Australian National Task Force on Cannabis (NTFC) was a specialised unit formed in April 1992 under the aegis of the Ministerial Council on Drug Strategy (MCDS) who are responsible for implementing national consistency in policy principles related to Australia's National Drug Strategy.
David Joshua Handelsman, (AO) is trained in Medicine and Endocrinology. His expertise is in testicular function and androgen physiology, pharmacology, and toxicology. His experience spans basic, clinical, and public health domains including a recent focus on genetic models of androgen action, steroid mass spectrometry, and anti-doping science. He was Australia's first Professor in Reproductive Endocrinology and Andrology. He has worked in the US, Australia, and Germany. His professional involvement includes the World Health Organization (WHO) Human Reproduction Programme's Male Task Force, the United Nations Fund for Population Activities, Endocrine Society of Australia, World Anti-Doping Agency's Health, Medicine and Research Committee, and Australian Drug Evaluation Committee.
Janice Clare Reid is an Australian academic and medical anthropologist, who has specialised in Aboriginal and refugee health. She was Vice-Chancellor of the University of Western Sydney from 1998 to 2013.
Open access (OA) to academic publications has seen extensive growth in Australia since the first open access university repository was established in 2001 and OA is a fundamental part of the scholarly publishing and research landscape in Australia. There are open access policies at the two major research funders: The National Health and Medical Research Council (NHMRC) and Australian Research Council (ARC) and around half of Australian Universities have an OA policy or statement. Open Access Australasia, the Council of Australian University Librarians (CAUL), and the Australian Library and Information Association (ALIA) are advocates for Open Access and related issues in Australia.
Professor Anne Kelso is an Australian biomedical researcher specialising in immunology and influenza. She is the Chief Executive Officer of the Australian Government's National Health and Medical Research Council (NHMRC).
The Australian Health Protection Principal Committee (AHPPC) is the peak decision-making committee for public health emergency management and disease control in the Commonwealth of Australia. It is chaired by the Chief Medical Officer of the Australian Government and comprises the chief health officers of the states and territories.
Emily Banks is an Australian epidemiologist and public health physician, working mainly on chronic disease. She is a Professor of Epidemiology and Public Health and Head of the Centre for Public Health Data and Policy at the Australian National University, and a visiting professor at the University of Oxford.